NASDAQ · Biotechnology

Whitehawk Therapeutics, Inc. (WHWK) Stock

$3.52 +1.44% NASDAQ: WHWK Healthcare

Valuation

MetricValue
Price$3.52
Market Cap$200.67M
P/E Ratio-3.30
P/B Ratio1.68
P/S Ratio30.13
EPS (TTM)$-0.33
52-Week High$5.50
52-Week Low$1.87
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-53.89%
ROA-41.15%
ROCE-47.05%
Gross Margin-1642.86%
Operating Margin-1628.57%
Net Margin-300.00%
Debt/Equity0.00
Current Ratio9.93

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$15.0M$24.0M$26.0M$7.0M
Operating Profit$-111.0M$-63.0M$-72.0M$-67.0M$-114.0M
Net Profit$-110.0M$-61.0M$-66.0M$-64.0M$-21.0M
EPS$-12.41$-2.69$-2.44$-2.36$-0.33
Op Margin-9930.1%-411.9%-295.4%-259.6%-1601.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$158.0M$184.0M$132.0M$70.0M$151.0M
Total Liabilities$22.0M$26.0M$27.0M$18.0M$15.0M
Cash$149.0M$39.0M$63.0M$29.0M$38.0M
Borrowings$1.0M$2.0M$1.0M$1.0M$0

Latest News

Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity GlobeNewswire · Jul 22, 2026 Akari Therapeutics, Whitehawk Therapeutics Collaborate to Develop ADC Cancer Treatments MT Newswires · Jul 21, 2026 Akari Therapeutics Enters Strategic Research Collaboration with Whitehawk Therapeutics GlobeNewswire · Jul 21, 2026 Biocytogen and Whitehawk Therapeutics Enter Global Collaboration for Bispecific Antibody ADC Development Business Wire · Jul 7, 2026 B. Riley Initiates Whitehawk Therapeutics at Buy With $10 Price Target MT Newswires · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-22.0M$-50.0M$-60.0M$-60.0M$-97.0M
Investing Cash Flow$25.0M$-133.0M$79.0M$24.0M$11.0M
Financing Cash Flow$-9.0M$0$0$0$-6.0M
Net Cash Flow$145.0M$-110.0M$24.0M$-34.0M$9.0M
Free Cash Flow$-22.0M$-50.0M$-64.0M$-61.0M$-98.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-1.55
FCF Yield-32.88%
Quick Ratio17.38
Interest Coverage0.00
Return 1Y85.85%
Return 3Y-33.62%
Return 5Y-87.36%

Ownership

Insiders Held13.38%
Institutions Held73.24%
Institutions Float Held84.56%
Institutional HolderSharesReport Date
QVT Financial LP4,615,7092026-03-31
Orbimed Advisors LLC.4,166,0002026-03-31
Suvretta Capital Management, LLC3,700,0002026-03-31
Acuta Capital Partners LLC3,410,4022026-03-31
Avoro Capital Advisors LLC2,849,4022026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATOSAtossa Therapeutics, Inc. $2.44 +0.83% -0.54 $24.34M 0.00%
CLNNClene Inc. $3.86 -0.52% -1.10 $49.32M 0.00%
CNTXContext Therapeutics Inc. $0.30 +1.74% -0.64 $27.95M 0.00%
IMMXImmix Biopharma, Inc. $9.46 +1.83% -11.00 $514.64M 0.00%
MGNXMacroGenics, Inc. $3.74 +5.35% -16.25 $237.73M 0.00%

About Whitehawk Therapeutics, Inc.

Whitehawk Therapeutics, Inc. is led by CEO David J. Lennon, employs 40 people, headquartered in US, publicly traded since 2017.

Whitehawk Therapeutics, Inc. (WHWK) stock trades at $3.52 with a market capitalization of $200.67M. The stock is valued at a price-to-earnings (P/E) ratio of -3.30, price-to-book of 1.68, price-to-sales of 30.13. Over the past 52 weeks the stock has ranged between $1.87 and $5.50, and currently trades 36.0% below its 52-week high.

On profitability, Whitehawk Therapeutics, Inc. generates a return on equity (ROE) of -53.89%, return on capital employed of -47.05%, an operating margin of -1628.57%, a net profit margin of -300.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides